Try our Advanced Search for more refined results

Galena Biopharma Investor Claims Stock Votes Miscounted

By Matt Chiappardi (April 28, 2017, 3:55 PM EDT) -- An investor in Galena Biopharma Inc. launched a putative class action in the Delaware Chancery Court late Thursday, claiming that at two shareholder meetings, the company improperly counted stockholder votes and then went ahead as if its proposals had passed when they actually didn't....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!